Novartis' programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. First introduced in ...
Unlock the power of Reactive Programming in .NET 9 with C#! This guide explores best practices, real-world examples, and performance optimization techniques for building responsive, scalable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback